Turmoil in the financial markets is having a disproportionate impact on biotech – and coupled with extra caution from regulators, is threatening innovation.
Brussels is abuzz with speculation that Europe’s fragmented, costly and complex patent regime is about to reform – aided by advances in machine translation. But support is not unanimous.
ICAMS, the Interdisciplinary Centre for Advanced Materials Simulation established with a €24 million contribution from leading German firms, has been officially opened by the Ruhr University.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.